Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
europe
2
×
artificial intelligence
balderton capital
boehringer ingelheim
clinical trials
dna sequencing
eli lilly
empagliflozin
europe blog main
europe top stories
fda
fundings & exits
health
ibm watson
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
predictive medicine
slgt2 inhibitor
software as a service
sophia genetics
tc
type 1 diabetes
type 2 diabetes
What
patients
2
×
algorithms
analytics
approval
balderton
based
better
bid
big
biotech
boehringer
built
cancer
clinicians
data
diabetes
diagnoses
diagnostic
diagnostics
diseases
drug
eli
enhance
expand
expertise
fallen
faster
fda
genetics
genomic
harnesses
healthcare
hoping
ibm
ingelheim
joins
leading
lilly
marketed
medical
Language
unset
Current search:
patients
×
europe
×
biotech
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@techcrunch.com
6 years ago
Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics
